I wonder if the phase 2 burns trial can provide and data to support the fact there is no resistance developed after multiple use. Obviously they have already stated it has worked against infections that were until now resistant to multiple existing treatments. If they can categorically prove it does not increase resistance with multiple use then I am hoping that would make it a go to first choice treatment, rather than something that is kept until all else fails, which seems to have hindered anti biotic development in the past.
- Forums
- ASX - By Stock
- Ann: Update on Phase I/II Clinical Trial for Burn Wound Infection
RCE
recce pharmaceuticals ltd
Add to My Watchlist
1.30%
!
39.0¢

I wonder if the phase 2 burns trial can provide and data to...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
39.0¢ |
Change
0.005(1.30%) |
Mkt cap ! $112.0M |
Open | High | Low | Value | Volume |
38.5¢ | 39.0¢ | 38.0¢ | $279 | 728 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 5005 | 38.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.0¢ | 49843 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 5005 | 0.385 |
2 | 24610 | 0.380 |
5 | 6386 | 0.375 |
2 | 5261 | 0.370 |
2 | 33181 | 0.365 |
Price($) | Vol. | No. |
---|---|---|
0.390 | 49843 | 1 |
0.395 | 261 | 1 |
0.400 | 23365 | 3 |
0.410 | 25471 | 1 |
0.435 | 5115 | 1 |
Last trade - 14.35pm 31/07/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |